Thomas, McNerney & Partners

Summary

Thomas, McNerney & Partners appeared to be the VC, which was created in 2003. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Stamford.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Thomas, McNerney & Partners, startups are often financed by Sanderling Ventures, Versant Ventures, Techno Venture Management. The meaningful sponsors for the fund in investment in the same round are Investor Growth Capital Limited, H.I.G. Capital, Sanderling Ventures. In the next rounds fund is usually obtained by Investor Growth Capital Limited, Accuitive Medical Ventures, Versant Ventures.

This organization was formed by Karen Boezi, Peter H. McNerney. Besides them, we counted 1 critical employee of this fund in our database.

Among the most popular portfolio startups of the fund, we may highlight Auspex Pharmaceuticals, Celator Pharmaceuticals, Elron Electronic Industries. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Therapeutics, Biopharma.

The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2010. This Thomas, McNerney & Partners works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2010. Speaking about the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations.